Navigation Links
Bioscience for a Better Tomorrow – Exploring Recent Breakthroughs in Medical Technology on Advancements TV Series
Date:8/1/2019

Advancements with Ted Danson to focus on innovative medical technologies for personalized treatment. Check your local listings for more information.

Factor Bioscience Inc. (Factor) is pioneering nucleic-acid and cell-based technologies to advance the study and treatment of cancer and genetic and age-related diseases. This segment of Advancements will explore how Factor Bioscience is building the future of regenerative medicine by targeting and repairing the molecular origins of disease.

“Factor is excited to participate in Advancements and to share our discoveries in the burgeoning field of engineered cellular medicine,” explains Dr. Matt Angel, Co-Founder and CEO of Factor Bioscience. “These new technologies will allow us to fundamentally alter the way our bodies function, to effectively treat, and eventually eliminate currently untreatable diseases.”

The show will highlight Factor’s scientists, who developed the fastest, highest-efficiency method for reprogramming somatic cells to a pluripotent stem-cell state – a key invention now recognized by numerous patents. Viewers will see how this technology, which enables the production of patient-specific engineered cells for transplantation, has wide-ranging applications in cancer, neurodegenerative diseases, including Alzheimer’s disease and autoimmune diseases, along with multiple sclerosis and personalized regenerative medicine.

The technologies underlying this breakthrough also form the foundation of Factor’s protein-replacement and gene-editing platforms, allowing the company to target disease at the molecular level.

About Factor Bioscience:
Based in Cambridge, Massachusetts, Factor Bioscience is developing nucleic-acid and cell-based therapeutics using its patented mRNA, cell-reprogramming, and gene-editing technologies. Factor is focused on creating precision medical treatments, including engineered cellular medicines for people living with cancer and serious genetic and age-related diseases.

For more information, visit: http://www.factorbio.com.

About Advancements and DMG Productions:
The Advancements series is an information-based educational show targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today’s consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming on which both viewers and networks depend.

For more information, please visit http://www.AdvancementsTV.com or call Richard Lubin at 866-496-4065.

Read the full story at https://www.prweb.com/releases/bioscience_for_a_better_tomorrow_exploring_recent_breakthroughs_in_medical_technology_on_advancements_tv_series/prweb16471468.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
2. LiquiTech and Spartan Bioscience Partner to Bring Innovative, Real-time Legionella Detection to Health Care Sector
3. Landsec and Spartan Bioscience Trial the World’s First On-Site Legionella DNA Test in the UK
4. Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services
5. SeqOnce Biosciences Launches RhinoSeq™ Rapid DNA Library Preparation Kit
6. StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson’s Disease is Published
7. Fluxion Biosciences Receives National Cancer Institute Grant for Development of ERASE-Seq Liquid Biopsy Technology
8. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
9. Tosoh Bioscience LLC invests in Semba Biosciences
10. ACEA Biosciences Launches xCELLigence® RTCA Software Pro to Further Enhance Immuno-Oncology Experimental Design and Analysis
11. ACEA Biosciences Releases New Version of NovoExpress® Flow Cytometry Software.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... 2019 , ... In October, Massachusetts stem cell biotechnology company ... a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical ... stem cells. This problem affects all patients receiving stem cell treatments, including ...
(Date:11/5/2019)... WA (PRWEB) , ... November 05, 2019 , ... ... & Amato Dentistry, providing state-of-the-art cosmetic and restorative dentistry to Seattle, WA, including ... her Doctor of Dental Surgery degree from the University of Washington, Dr. Kopp ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards ... analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate ... , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal ...
Breaking Biology News(10 mins):
(Date:10/30/2019)... ... 2019 , ... Western University of Health Sciences held Innovation ... in educating the next generation of health care providers. , The event, organized ... administrators and representatives of companies working with the University on a range of ...
(Date:10/26/2019)... PHILADELPHIA (PRWEB) , ... October 24, 2019 , ... ... its investment in Bichsel Medical Marketing Group (BMMG), a boutique healthcare-specific ... enhance the offerings of its in-house Healthcare Strategy Division. , Healthcare clients in ...
(Date:10/22/2019)... , ... October 22, 2019 , ... ... has announced that its lead program, DBI-001, met its primary safety endpoints, with ... labeled phase 2a clinical trial for the treatment of interdigital tinea pedis (athlete’s ...
(Date:10/10/2019)... ... October 09, 2019 , ... ... MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the ... in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine ...
Breaking Biology Technology: